Dynamic late gadolinium enhancement simply quantified using myocardium to lumen signal ratio: Normal range of ratio and diffuse abnormal enhancement of cardiac amyloidosis

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 1, 2011, Pages 50-55

  Kono, Atsushi K ^a,b   Yamada, Naoaki ^a   Higashi, Masahiro ^a   Kanzaki, Suzu ^a   Hashimura, Hiromi ^a   Morita, Yoshiaki ^a   Sakuma, Toshiharu ^a   Noguchi, Teruo ^a   Naito, Hiroaki ^a   Sugimura, Kazuro ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

cardiac amyloidosis; cardiomyopathy; late gadolinium enhancement; magnetic resonance imaging

Indexed keywords

AMYLOID PROTEIN; BETA 2 MICROGLOBULIN; GADOLINIUM; GADOLINIUM PENTETATE; IMMUNOGLOBULIN LIGHT CHAIN; PREALBUMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART; HEART AMYLOIDOSIS; HEART MUSCLE BIOPSY; HEART VENTRICLE WALL; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MYOCARDIUM TO LUMEN SIGNAL RATIO; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGNAL INTENSITY RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; CARDIOMYOPATHIES; CONTRAST MEDIA; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIUM; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 79959590375     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22602     Document Type: Article

References (24)

1. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-223. (Pubitemid 32151298)
2. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002. (Pubitemid 29529292)
3. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
4. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ,. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003; 41: 1561-1567. (Pubitemid 36543376)
5. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54-59. (Pubitemid 36859020)
6. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690. (Pubitemid 40704507)
7. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111: 186-193. (Pubitemid 40139730)
8. Perugini E, Rapezzi C, Piva T, et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006; 92: 343-349.
9. vanden Driesen RI, Slaughter RE, Strugnell WE,. MR findings in cardiac amyloidosis. AJR Am J Roentgenol 2006; 186: 1682-1685. (Pubitemid 46112533)
10. Yazaki M, Tokuda T, Nakamura A, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000; 274: 702-706. (Pubitemid 30663682)
11. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999; 211: 698-708. (Pubitemid 29249466)
12. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP,. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52: 141-146. (Pubitemid 39295266)
13. Hosch W, Bock M, Libicher M, et al. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Invest Radiol 2007; 42: 636-642. (Pubitemid 47262932)
14. Krombach GA, Hahn C, Tomars M, et al. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging 2007; 25: 1283-1287. (Pubitemid 46870288)
15. Klein C, Schmal TR, Nekolla SG, Schnackenburg B, Fleck E, Nagel E,. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2007; 9: 653-658. (Pubitemid 46956899)
16. Messroghli DR, Walters K, Plein S, et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007; 58: 34-40. (Pubitemid 47229915)
17. Messroghli DR, Plein S, Higgins DM, et al. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Radiology 2006; 238: 1004-1012. (Pubitemid 43289933)
18. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ,. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008; 10: 54.
19. Flacke SJ, Fischer SE, Lorenz CH,. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 2001; 218: 703-710. (Pubitemid 32172551)
20. Huber A, Schoenberg SO, Spannagl B, et al. Single-shot inversion recovery TrueFISP for assessment of myocardial infarction. AJR Am J Roentgenol 2006; 186: 627-633. (Pubitemid 46100248)
21. Naito H, Saito H, Takamiya M, et al. Quantitative assessment of myocardial enhancement with iodinated contrast medium in patients with ischemic heart disease by using ultrafast x-ray computed tomography. Invest Radiol 1992; 27: 436-442.
22. Arheden H, Saeed M, Higgins CB, et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 2000; 215: 520-528. (Pubitemid 30237855)
23. Morita Y, Yamada N, Noguchi T, et al. Late gadolinium enhancement can visualize the periinfarct zone in acute myocardial infarction. Proc 18th Annual Meeting ISMRM, Stockholm; 2010. p 1286.
24. Hashimura H, Yamada N, Kono A, et al. Late gadolinium enhancement in hypertrophic cardiomyopathy and cardiac amyloidosis; differentiation using myocardium to lumen ratio. Proc European Congress of Radiology, Vienna; 2010. p C-0677.